Coronavirus stock A second primary-care company is gearing up to go public
Hello, Welcome to Dispensed, Business Insider’s weekly healthcare newsletter. This week, amid rising coronavirus hospitalizations and political attacks on Dr. Anthony Fauci for his response to the pandemic, we covered new developments in the vaccine race, what’s on deck for the next coronavirus stimulus package, and another primary care IPO that’s in the works. But first:Subscribe here to…
This week, amid rising coronavirus hospitalizations and political attacks on Dr. Anthony Fauci for his response to the pandemic, we covered new developments in the vaccine race, what’s on deck for the next coronavirus stimulus package, and another primary care IPO that’s in the works.
FILE PHOTO: U.S. Senate Majority Leader McConnell speaks to a reporter as he departs the Senate floor after a vote at the U.S. Capitol in Washington
Reuters
All the excitement around companies looking at potential treatments and vaccines has led to inflated stock prices for some of the biotech companies touting their efforts, a reality that makes RBC’s top dealmaker Andrew Callaway wary.
Speaking of valuations, Moderna’s stock has been surging since its positive results, and the company is now valued at $34 billion. Analysts at some of Wall Street’s top banks expect the company’s stock price to rise even more.
To that end, I read through the full Oak Street S-1 so you don’t have to. It reveals a lot about the company’s financials and its backers (Humana is much more involved than I realized).
When the pandemic hit the US, a significant portion of medical visits moved online, leaving medical practices and health systems to navigate that new reality.
Theoretically, that should make going to the doctor a more efficient and less expensive process, both for patients and hospitals. That’s not the case — at least not yet.
Meanwhile, amid the pandemic, health systems are still making the move onto the cloud as a way to store hospital information.
Blake spoke to the chief information officer at Northwell Health about why cloud provider Microsoft has become a favorite among health systems as they make that transition.
Finally, Blake and Hilary Brueck have the story on the controversy surrounding how hospitals share their coronavirus data with the federal government.
On Wednesday, hospitals stopped reporting information on capacity, staffing, and supplies directly to the Centers for Disease Control and Prevention. They’re sending it to a database managed by the Department of Health and Human Services (of which the CDC is a part) instead.